Category:
Published on: 18 Dec 2024
First Hybrid Workshop on Precision Health and Medicine
Synergizing our strengths in new technologies in omics, digital sciences, and translational medicine to advance patient care.
This event is organized in partnership between University of Bern and 不良研究所. This partnership between the universities aims to synergistically harness the power of new technologies in omics, digital sciences, and translational medicine to advance patient care.
Event details:听
Category:
Published on: 25 Nov 2024
YCharOS antibody characterization platform addresses the 鈥渞eproducibility crisis鈥� in research
An innovative research project led by researchers at The Neuro has been awarded $1.5M by the Government of Quebec through CQDM.
YCharOS is an innovative platform led by neuroscientists Peter McPherson and Carl Laflamme that validates antibody reagents for human proteins.
Category:
Published on: 12 Nov 2024
Dear Colleagues,
Please see the next Medical Genetics Grand Rounds scheduled talk below:
Category:
Published on: 12 Nov 2024
We're happy to announce that the 2024 Amazing Brain Science Talks video recordings are officially live on our YouTube channel. Whether you're tuning in for the first time or revisiting your favourite moments, don't miss out on these compelling talks!
Category:
Published on: 11 Nov 2024
$1M grant from The Weston Family Foundation will pave the way for earlier intervention in REM sleep behaviour disorder and Parkinson鈥檚 disease
REM sleep behaviour disorder (RBD) is an often debilitating condition that causes people to act out in their sleep, sometimes violently. What鈥檚 worse, people with the disorder often go on to develop Parkinson鈥檚 disease.
Category:
Published on: 8 Nov 2024
Philippe Gros appointed Chief Scientific Officer of D2R
Philippe Gros has been appointed Chief Scientific Officer (CSO) of 不良研究所鈥檚 DNA to RNA (D2R) Initiative, effective September 30, 2024. Prior to this role, he served as Deputy Vice-President (Research and Innovation) at 不良研究所. This appointment follows a thorough international search, with the selection committee enthusiastic about their recommendation. Notably, Gros was instrumental in writing the application for the D2R Initiative, laying the groundwork for its success.
Category:
Published on: 31 Oct 2024
D2R welcomes RNA and genomic researchers to Universit茅 de Sherbrooke
Montreal 鈥� October 31, 2024 鈥� 不良研究所鈥檚 DNA to RNA (D2R) research initiative is proud to announce the appointment of three new researchers at Universit茅 de Sherbrooke, marking the inaugural recipients of the D2R鈥檚 New Faculty Start-Up funding program. Universit茅 de Sherbrooke is a partner institution in the D2R initiative, working collaboratively to advance genomic and RNA research.
Category:
Published on: 31 Oct 2024
$1.14 million from CIHR will resolve treatment roadblocks for rare brain disorders
听
Gene therapy for rare neurological disorders will move one step forward thanks to a $1.14 million grant from the Canadian Institutes of Health Research (CIHR).
Category:
Published on: 23 Oct 2024
Thomas Durcan鈥檚 project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment
An innovative new program based at The Neuro has received $2.6 million from the CQDM and the Brain Canada Foundation.
Category:
Published on: 16 Oct 2024
MRI data from large sample shows increased whole-brain connectivity in people with a second language
Neuroplasticity is the brain鈥檚 ability to build connections within itself, adapting to the surrounding environment. The brain is most plastic in childhood, forming new pathways in reaction to stimuli such as language.
Category:
Published on: 11 Oct 2024
The 2024 Nobel Prize in Physiology or Medicine has been awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Category:
Published on: 8 Oct 2024
RNA Nanotechnology - Gordon Research Conference (GRC)
Controlling RNA Sequence for Diagnostics and Therapeutic DeliveryJanuary 5 - 10, 2025
Ventura, California, United States
Category:
Published on: 8 Oct 2024
Scientists use stem cells to follow development of protein bodies characteristic of neurological disease
Category:
Published on: 8 Oct 2024
Congratulations to Dr. Raquel Cuella Martin on receiving the prestigious Gairdner Foundation Early Career Investigator Award.
As an Assistant Professor of Human Genetics at 不良研究所, Dr. Cuella Martin is pushing the boundaries of science with her lab, which uses precision genome editing to tackle complex biological problems.
Category:
Published on: 3 Oct 2024
Pages
